For the original article, please follow this link. This article was reviewed by Dr. Emily Bowman, one of our subject matter experts. Brief Summary: This study by Denis Pierron et al. investigated the reliability of self-reported smell and taste change numbers across France as an indicator to predict surges of COVID-19 hospital admissions and a basis for … Continue reading Smell and Taste Changes: The Best Way to Guide Lockdown Policy?
This post was reviewed by Dr. Emily Bowman, one of our subject matter experts. The paper we’re demystifying today can be found here, if you’d like to tag along! Summary Researchers investigated the immune system’s T-cell response to the SARS-CoV-2 virus in people who were completely unexposed to COVID-19, people who were exposed to COVID-19 … Continue reading Investigating T cell Immune Response to SARS-CoV-2
Image credit: “Petri dishes with cultures of bacteria grown on agar jelly.” by M. J. Richardson is under a CC BY-SA 2.0 License. This post was reviewed by Dr. Brett Finlay, one of our subject matter experts. This study was conducted by researchers from The Chinese University of Hong Kong. The paper we’ll be demystifying … Continue reading The In-Crowd: SARS-CoV-2 vs. Your Microbiome
This post was reviewed by Dr. Jasmin Chahal, one of our subject matter experts. For the original article, please follow this link. TL;DR: Compared to other coronaviruses (SARS-CoV and HCoV-NL63), SARS-CoV-2 spreads much more efficiently in a short time although all three coronaviruses use the same receptor to enter the cell and infect it. In … Continue reading Effect of SARS-CoV-2 infection in human airway cells
This post was reviewed by Dr. Zachary Benet, one of our subject matter experts. The paper we’re demystifying today can be found here, if you’d like to follow along. TL;DR BNT162b1 is an RNA-based vaccine against SARS-CoV-2. This Phase 1/2 clinical data is promising, because it shows that vaccination causes a strong antibody response, including neutralizing … Continue reading A Peek at Pfizer’s Vaccine Candidate